Discontinuation of nucleot(s)ide analogue therapy in HBeAg-negative chronic hepatitis B: a meta-analysis

中止 医学 乙型肝炎表面抗原 HBeAg 内科学 胃肠病学 恩替卡韦 失代偿 肝细胞癌 乙型肝炎 乙型肝炎病毒 拉米夫定 免疫学 病毒
作者
Samuel Hall,Sara Vogrin,Olivia Wawryk,Gareth Burns,Kumar Visvanathan,Vijaya Sundararajan,Alexander Thompson
出处
期刊:Gut [BMJ]
卷期号:: gutjnl-323979 被引量:57
标识
DOI:10.1136/gutjnl-2020-323979
摘要

Background and aims Sustained virological suppression and hepatitis B surface antigen (HBsAg) loss have been described after nucleot(s)ide analogue (NA) discontinuation for patients with hepatitis B e antigen (HBeAg)-negative chronic hepatitis B (CHB). We performed a meta-analysis of the clinical outcomes after NA discontinuation for HBeAg-negative CHB. Methods Studies involving NA cessation in HBeAg-negative CHB individuals with a median follow-up of ≥12 months were included. Participants were HBeAg-negative at the time of NA initiation. Random effects meta-analyses were performed for the following clinical outcomes: (1) virological relapse (VR) at 6 and 12 months; (2) clinical relapse (CR) at 6 and 12 months and (3) HBsAg loss. Effect of other variables was estimated using subgroup analysis and meta-regression. Studies including patients stopping entecavir (ETV) and/or tenofovir disoproxil fumarate (TDF) were considered separately to studies including patients stopping older generation NA. Results N=37 studies met inclusion criteria. Cumulative incidence of VR and CR after stopping ETV/TDF was 44% and 17% at 6 months and 63% and 35% at 12 months. Similar relapse rates were observed after stopping older NAs. Among patients stopping ETV/TDF, TDF cessation was associated with increased CR rates at 6 months versus ETV. There was an association between follow-up ≥4 years and HBsAg loss rates when stopping older NAs. Hepatic decompensation and hepatocellular carcinoma were rare but occurred more frequently in studies including cirrhotic individuals. Conclusion VR is common after NA discontinuation, however, CR was only seen in one-third of patients at 12 months. Stopping NA therapy can be followed by HBsAg clearance, and rates are higher with longer follow-up.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
2秒前
4秒前
5秒前
5秒前
脑洞疼应助科研小狗采纳,获得10
6秒前
6秒前
7秒前
8秒前
456发布了新的文献求助10
8秒前
Hongtauo发布了新的文献求助10
10秒前
10秒前
caibao发布了新的文献求助10
10秒前
11秒前
13秒前
orixero应助星期五采纳,获得10
13秒前
一叶知秋发布了新的文献求助10
15秒前
15秒前
456完成签到,获得积分10
17秒前
林爷完成签到,获得积分10
17秒前
zzp完成签到,获得积分10
19秒前
19秒前
Richard完成签到 ,获得积分10
22秒前
科研小狗发布了新的文献求助10
22秒前
24秒前
乔若灵完成签到 ,获得积分10
26秒前
香蕉觅云应助紫薯球采纳,获得10
26秒前
27秒前
29秒前
星期五发布了新的文献求助10
29秒前
jackjiang关注了科研通微信公众号
30秒前
Rondab应助王晓宇采纳,获得10
30秒前
cyy完成签到 ,获得积分10
31秒前
qing123发布了新的文献求助30
31秒前
共享精神应助博修采纳,获得10
31秒前
devil完成签到,获得积分10
31秒前
念姬发布了新的文献求助10
33秒前
星中一点光完成签到,获得积分10
33秒前
科研通AI2S应助灰底爆米花采纳,获得10
35秒前
35秒前
高分求助中
Ophthalmic Equipment Market by Devices(surgical: vitreorentinal,IOLs,OVDs,contact lens,RGP lens,backflush,diagnostic&monitoring:OCT,actorefractor,keratometer,tonometer,ophthalmoscpe,OVD), End User,Buying Criteria-Global Forecast to2029 2000
A new approach to the extrapolation of accelerated life test data 1000
Cognitive Neuroscience: The Biology of the Mind 1000
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
A Preliminary Study on Correlation Between Independent Components of Facial Thermal Images and Subjective Assessment of Chronic Stress 500
Technical Brochure TB 814: LPIT applications in HV gas insulated switchgear 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3962882
求助须知:如何正确求助?哪些是违规求助? 3508809
关于积分的说明 11143356
捐赠科研通 3241711
什么是DOI,文献DOI怎么找? 1791651
邀请新用户注册赠送积分活动 873058
科研通“疑难数据库(出版商)”最低求助积分说明 803579